F La Rosée

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Peritoneal Dialysis

Ejection Fraction

Coronavirus Disease

Combination Therapy

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

J Hammersen, Sebastian Birndt, K Döhner, Philipp Alexander Reuken, A Stallmach, P Sauerbrey, F La Rosée, M Pfirrmann, C Fabisch, M Weiss, K Träger, H Bremer, S Russo, Gerald Illerhaus, D Drömann, S Schneider, Paul La Rosée, Andreas Hochhaus
The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial. Leukemia (2023)
Philipp Alexander Reuken, Maria Madeleine Rüthrich, A Hochhaus, J Hammersen, Michael Bauer, Paul La Rosée, F La Rosée, Andreas Stallmach
The impact of specific cytokine directed treatment on severe COVID-19. Leukemia 35 (12) (2021)
F La Rosée, H C Bremer, I Gehrke, A Kehr, A Hochhaus, Sebastian Birndt, M Fellhauer, M Henkes, B Kumle, S G Russo, Paul La Rosée
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation. Leukemia 34 (7) (2020)